230 related articles for article (PubMed ID: 25936308)
1. Treatment of minor severe acquired haemophilia. Is there a rationale for immunoadsorption?
Goldmann G; Marquardt N; Horneff S; Oldenburg J; Zeitler H
Atheroscler Suppl; 2015 May; 18():74-9. PubMed ID: 25936308
[TBL] [Abstract][Full Text] [Related]
2. Long term outcome of patients with acquired haemophilia--a monocentre interim analysis of 82 patients.
Zeitler H; Goldmann G; Marquardt N; Ulrich-Merzenich G
Atheroscler Suppl; 2013 Jan; 14(1):223-8. PubMed ID: 23357169
[TBL] [Abstract][Full Text] [Related]
3. Immunoadsorption in the treatment of acquired haemophilia.
Zeitler H; Ulrich-Merzenich G; Panek D; Goldmann G; Vidovic N; Brackmann HH; Oldenburg J
Atheroscler Suppl; 2009 Dec; 10(5):122-5. PubMed ID: 20129389
[TBL] [Abstract][Full Text] [Related]
4. The relevance of the bleeding severity in the treatment of acquired haemophilia - an update of a single-centre experience with 67 patients.
Zeitler H; Ulrich-Merzenich G; Goldmann G; Vidovic N; Brackmann HH; Oldenburg J
Haemophilia; 2010 May; 16(102):95-101. PubMed ID: 19040429
[TBL] [Abstract][Full Text] [Related]
5. Immunoadsorption for pregnancy-associated severe acquired hemophilia.
Zeitler H; Ulrich-Merzenich G; Marquardt N; Oldenburg J; Goldmann G
Ther Apher Dial; 2014 Feb; 18(1):103-10. PubMed ID: 24499091
[TBL] [Abstract][Full Text] [Related]
6. Treatment of acquired hemophilia by the Bonn-Malmo Protocol: documentation of an in vivo immunomodulating concept.
Zeitler H; Ulrich-Merzenich G; Hess L; Konsek E; Unkrig C; Walger P; Vetter H; Brackmann HH
Blood; 2005 Mar; 105(6):2287-93. PubMed ID: 15542586
[TBL] [Abstract][Full Text] [Related]
7. Acquired haemophilia syndrome: pathophysiology and therapy.
Elezović I
Srp Arh Celok Lek; 2010 Jan; 138 Suppl 1():64-8. PubMed ID: 20229686
[TBL] [Abstract][Full Text] [Related]
8. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report.
Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M
Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266
[TBL] [Abstract][Full Text] [Related]
9. Acquired haemophilia A. First line treatment with calcineurin inhibitors and steroid pulses: a 10-year follow-up study.
Pardos-Gea J; Altisent C; Parra R; Vilardell-Tarrès M; Ordi-Ros J
Haemophilia; 2012 Sep; 18(5):789-93. PubMed ID: 22429259
[TBL] [Abstract][Full Text] [Related]
10. [Acquired haemophilia due to autoantibodies against factor VIII].
von Depka Prondzinski M
Hamostaseologie; 2003 Feb; 23(1):28-35. PubMed ID: 12567197
[TBL] [Abstract][Full Text] [Related]
11. Identifying risk factors and optimizing standard of care for patients with acquired haemophilia A: Results from a Czech patient cohort.
Salaj P; Geierová V; Ivanová E; Loužil J; Pohlreichová V; Hrachovinová I; Dulíček P
Haemophilia; 2020 Jul; 26(4):643-651. PubMed ID: 32590889
[TBL] [Abstract][Full Text] [Related]
12. Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies.
Holme PA; Brosstad F; Tjønnfjord GE
Haemophilia; 2005 Sep; 11(5):510-5. PubMed ID: 16128896
[TBL] [Abstract][Full Text] [Related]
13. [Acquired haemophilia].
Buczma A; Windyga J
Pol Arch Med Wewn; 2007; 117(5-6):241-5. PubMed ID: 18030874
[TBL] [Abstract][Full Text] [Related]
14. [Acquired haemophilia A: two cases].
de Vitry A; Valois A; Weinborn M; Dupuy-de Fonclare AL; Cuny JF; Barbaud A; Schmutz JL
Ann Dermatol Venereol; 2014; 141(6-7):441-5. PubMed ID: 24951143
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study.
Tiede A; Klamroth R; Scharf RE; Trappe RU; Holstein K; Huth-Kühne A; Gottstein S; Geisen U; Schenk J; Scholz U; Schilling K; Neumeister P; Miesbach W; Manner D; Greil R; von Auer C; Krause M; Leimkühler K; Kalus U; Blumtritt JM; Werwitzke S; Budde E; Koch A; Knöbl P
Blood; 2015 Feb; 125(7):1091-7. PubMed ID: 25525118
[TBL] [Abstract][Full Text] [Related]
16. [The modified Bonn Malmö protocol (MBMP) in the treatment of acquired haemophilia A].
Zeitler H; Ulrich-Merzenich G; Walger P; Düsing R; Vetter H; Brackmann HH
Dtsch Med Wochenschr; 2006 Jan; 131(4):141-7. PubMed ID: 16429335
[TBL] [Abstract][Full Text] [Related]
17. New protocol for immune tolerance induction in acquired hemophilia.
Nemes L; Pitlik E
Haematologica; 2000 Oct; 85(10 Suppl):64-8. PubMed ID: 11187874
[TBL] [Abstract][Full Text] [Related]
18. Successful immunoadsorption of life-threatening bleeding in factor VIII inhibitor disease, but no long-term remission with anti-CD20 treatment.
Grahammer F; Fischer KG
BMJ Case Rep; 2015 Aug; 2015():. PubMed ID: 26323976
[TBL] [Abstract][Full Text] [Related]
19. Extracorporeal Treatment for the Acute und Long-Term Outcome of Patients with Life-Threatening Acquired Hemophilia.
Zeitler H; Ulrich-Merzenich G; Panek D; Goldmann G; Vidovic N; Brackmann HH; Oldenburg J
Transfus Med Hemother; 2012 Aug; 39(4):264-270. PubMed ID: 22969696
[TBL] [Abstract][Full Text] [Related]
20. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).
Knoebl P; Marco P; Baudo F; Collins P; Huth-Kühne A; Nemes L; Pellegrini F; Tengborn L; Lévesque H;
J Thromb Haemost; 2012 Apr; 10(4):622-31. PubMed ID: 22321904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
